Factor XIII for preventing heavy bleeding after childbirth
Part of Blood & lymphatic, Heart & circulation, Women’s health & pregnancy clinical trials.
This study tests whether giving factor XIII, a natural protein that helps blood clot, can reduce excessive bleeding after vaginal delivery. It is for women who are at least 30 weeks pregnant with a single baby and who do not have certain medical conditions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are planning a vaginal delivery (not a scheduled cesarean).
- You are carrying one baby (not twins or triplets), and the pregnancy is healthy.
- Your due date is at least 30 weeks and 0 days along.
- Your weight at hospital admission is less than 100 kg (about 220 lbs).
- You do not have certain medical conditions (such as preeclampsia, a blood clotting disorder, or severe anemia).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether tranexamic acid can prevent heavy bleeding after a planned or urgent cesarean delivery in people with placenta previa. If you qualify, you may receive the study drug to help your body keep blood loss lower during and after surgery.
This trial tests whether tranexamic acid (a medicine that helps blood clot) can prevent heavy bleeding after delivery in women who are at higher risk. If it works, it may lower the chance of serious postpartum bleeding and related complications.
This trial tests if a medicine called tranexamic acid can reduce the risk of heavy bleeding after a C-section for women who have certain autoimmune diseases. It aims to help prevent postpartum hemorrhage in this specific group.
This study looks at how tranexamic acid, a medicine to reduce bleeding, is given to people who have heavy bleeding after a cesarean delivery. It may help doctors improve treatment for this condition.
This trial is testing a short course of a low-dose blood thinner (heparin) to prevent dangerous blood clots in the legs or lungs after childbirth. It is for women who have certain risk factors that make clots more likely.
This trial studies whether tranexamic acid, a medicine that helps blood clot, can prevent postpartum hemorrhage (heavy bleeding after delivery) in people having a planned C-section or likely vaginal delivery after 34 weeks. It may help lower the risk of dangerous bleeding around the time of birth.
Hear when a new Postpartum Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.